# Inflammatory Markers in Broncho-alveolar Lavage Fluid as Risk Factors for Lung Disease in Infants With Cystic Fibrosis: the I-BALL Study

> **NCT02907788** · — · COMPLETED · sponsor: **Erasmus Medical Center** · enrollment: 51 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02907788
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2021-01
- **Final completion:** 2021-01
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2021-11-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02907788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02907788, "Inflammatory Markers in Broncho-alveolar Lavage Fluid as Risk Factors for Lung Disease in Infants With Cystic Fibrosis: the I-BALL Study". Retrieved via MORVS 2026-10-18 from https://api.morvs.ai/clinical/NCT02907788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*